Yoshifumi Suga
No ORCID on file
· 1 paper in corpus
case-report
2020
A case of non-small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab
Programmed cell death protein 1 immune checkpoint inhibitor is an effective treatment for non-small cell lung cancer. Although hematological immune-related adverse events induced by antiprogrammed-cell-death-protein-1 immunotherapy have bee…